◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › VEEV

Veeva Systems Inc Class A (VEEV) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Technology · DATA UPDATED 2026-07-15

Veeva Systems Inc Class A (VEEV) operates in the Health Care Technology industry and is headquartered in Pleasanton, United States with about 7,928 employees. Its market capitalization is roughly $30 billion. In the fiscal year ended 2026-01-31, VEEV reported $3.2B in revenue and $909M in net income.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.

Interactive charts & full statements → Open the VEEV valuation workbench →

VEEV Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-04-30	2026-01-31	2025-01-31	2024-01-31	2023-01-31	2022-01-31	2021-01-31	2020-01-31	2019-01-31	2018-01-31	2017-01-31	2016-01-31	2015-01-31	2014-01-31	2013-01-31	2012-01-31	2011-01-31
Total Revenue	$3.3B	$3.2B	$2.7B	$2.4B	$2.2B	$1.9B	$1.5B	$1.1B	$862M	$691M	$544M	$409M	$313M	$210M	$130M	$61M	$29M
Gross Profit	$2.5B	$2.4B	$2.0B	$1.7B	$1.5B	$1.3B	$1.1B	$801M	$617M	$479M	$370M	$267M	$198M	$128M	$73M	$32M	$17M
Gross Margin %	75.0%	75.5%	74.5%	71.4%	71.7%	72.8%	72.1%	72.5%	71.5%	69.4%	68.1%	65.2%	63.1%	60.7%	56.0%	52.6%	57.7%
Operating Income (EBIT)	$956M	$916M	$691M	$429M	$459M	$505M	$378M	$286M	$223M	$158M	$121M	$79M	$70M	$39M	$30M	$7M	$5M
Operating Margin %	28.8%	28.7%	25.2%	18.2%	21.3%	27.3%	25.8%	25.9%	25.9%	22.9%	22.2%	19.2%	22.3%	18.7%	23.2%	10.8%	17.5%
Net Income	$942M	$909M	$714M	$526M	$488M	$427M	$380M	$301M	$230M	$151M	$78M	$54M	$40M	$24M	$3M	$4M	$4M
Net Margin %	28.4%	28.4%	26.0%	22.2%	22.6%	23.1%	25.9%	27.3%	26.7%	21.9%	14.3%	13.3%	12.9%	11.2%	2.7%	6.9%	13.4%
EBITDA	$1.3B	$1.2B	$959M	$621M	$488M	$505M	$407M	$306M	$237M	$179M	$135M	$87M	$74M	$42M	$31M	$7M	$5M
Earnings Per Share (EPS)	$5.63	$5.44	$4.32	$3.22	$3.00	$2.63	$2.36	$1.90	$1.47	$0.98	$0.53	$0.38	$0.28	$0.17	$0.03	$0.03	$0.03
Shares Outstanding (M)	166M	167M	165M	163M	162M	162M	161M	158M	156M	154M	148M	145M	144M	138M	126M	126M	126M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VEEV Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31
Total Revenue	$883M	$836M	$811M	$789M	$759M	$721M	$699M	$676M
Gross Profit	$660M	$622M	$612M	$594M	$585M	$540M	$525M	$506M
Gross Margin %	74.7%	74.5%	75.4%	75.3%	77.1%	74.9%	75.1%	74.8%
Operating Income (EBIT)	$273M	$246M	$241M	$196M	$234M	$188M	$181M	$166M
Operating Margin %	30.9%	29.4%	29.7%	24.8%	30.8%	26.1%	25.9%	24.6%
Net Income	$261M	$244M	$236M	$200M	$228M	$196M	$186M	$171M
Net Margin %	29.5%	29.2%	29.1%	25.4%	30.1%	27.1%	26.6%	25.3%
EBITDA	$362M	$329M	$333M	$275M	$309M	$255M	$252M	$236M
Earnings Per Share (EPS)	$1.57	$1.45	$1.41	$1.20	$1.37	$1.18	$1.13	$1.04
Shares Outstanding (M)	166M	168M	168M	167M	166M	166M	165M	165M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VEEV Free Cash Flow History

Cash flow	TTM → 2026-04-30	2026-01-31	2025-01-31	2024-01-31	2023-01-31	2022-01-31	2021-01-31	2020-01-31	2019-01-31	2018-01-31	2017-01-31	2016-01-31	2015-01-31	2014-01-31	2013-01-31	2012-01-31	2011-01-31
Cash from Operations (CFO)	$1.7B	$1.4B	$1.1B	$911M	$780M	$764M	$551M	$437M	$311M	$233M	$144M	$80M	$68M	$42M	$31M	$5M	$5M
Capital Expenditures (CapEx)	$21M	$29M	$21M	$26M	$14M	$14M	$9M	$3M	$8M	$10M	$7M	$21M	$27M	$2M	$1M	$1M	$0M
Free Cash Flow (FCF)	$1.6B	$1.4B	$1.1B	$885M	$767M	$750M	$543M	$434M	$302M	$224M	$137M	$59M	$41M	$40M	$30M	$4M	$4M
FCF Margin %	49.5%	43.4%	38.9%	37.5%	35.6%	40.5%	37.0%	39.3%	35.1%	32.4%	25.2%	14.4%	13.1%	19.0%	23.0%	6.7%	15.4%
Dividends Paid	—	—	—	—	—	$4M	—	—	—	$0M	$0M	$0M	$0M	$0M	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VEEV Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31
Cash from Operations (CFO)	$1.1B	$107M	$193M	$238M	$877M	$70M	$164M	$93M
Capital Expenditures (CapEx)	$2M	$7M	$6M	$6M	$6M	$5M	$4M	$3M
Free Cash Flow (FCF)	$1.1B	$100M	$186M	$232M	$871M	$65M	$160M	$90M
FCF Margin %	127.5%	11.9%	23.0%	29.4%	114.8%	9.0%	22.9%	13.3%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VEEV Balance Sheet History

Balance sheet	2026-04-30	2026-01-31	2025-01-31	2024-01-31	2023-01-31	2022-01-31	2021-01-31	2020-01-31	2019-01-31	2018-01-31	2017-01-31	2016-01-31	2015-01-31	2014-01-31	2013-01-31	2012-01-31
Total Assets	$9.1B	$9.0B	$7.3B	$5.9B	$4.8B	$3.8B	$3.0B	$2.3B	$1.7B	$1.2B	$918M	$706M	$545M	$370M	$90M	$41M
Cash & Cash Equivalents	$1.9B	$1.4B	$1.1B	$703M	$886M	$1.1B	$731M	$477M	$551M	$320M	$218M	$132M	$129M	$263M	$32M	$17M
Total Liabilities	$1.8B	$1.8B	$1.5B	$1.3B	$1.1B	$905M	$780M	$606M	$416M	$324M	$265M	$201M	$138M	$90M	$56M	$27M
Total Debt (Short + Long-Term)	$13M	$12M	$10M	$9M	$11M	$11M	$12M	$10M	$7M	$5M	$5M	$2M	$19M	$17M	$11M	$6M
Total Shareholders' Equity	$7.3B	$7.2B	$5.8B	$4.6B	$3.7B	$2.9B	$2.3B	$1.7B	$1.2B	$906M	$653M	$505M	$407M	$280M	$34M	$14M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VEEV viewer.

Other Companies in Health Care Technology

SOLV · Solventum — $14 billion

← VEEE All stocks VEL →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.